Clin2
NCT07345988Possibly a fitRecruiting

Babesiosis study in France

Human Babesiosis

Part of Infections clinical trials.

This study looks at cases of babesiosis, a rare tick-borne disease, in France from 2000 to 2024. It aims to understand how the disease affects people.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older
  • You have been diagnosed with babesiosis (confirmed by a blood test or a PCR test)
  • You were treated for babesiosis between January 1, 2000, and December 31, 2024
  • You agree to take part in the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07312474Recruiting
Study of Anaplasmosis Cases in Alsace

This study looks at people in Alsace, France, who have been diagnosed with anaplasmosis (a tick-borne infection). It aims to understand the disease's patterns and symptoms.

Strasbourg
NCT07191223Recruiting
Survey on tick-borne encephalitis knowledge for French doctors

This trial asks general practitioners in France to complete a survey about their knowledge of tick-borne encephalitis (a virus spread by ticks that can cause brain swelling). It helps researchers understand how well doctors know about this disease and how to prevent it.

Strasbourg
NCT07343089Recruiting
Study of Lyme disease during anti-CD20 treatment in France

This study looks at people who got a serious form of Lyme disease while being treated with a type of biologic drug called an anti-CD20 (such as rituximab). The goal is to learn more about these cases and improve care. You may join if you had Lyme disease confirmed by a DNA test within two years of taking this medicine.

Strasbourg
NCT06656351Recruiting· Phase 2
Study of tafenoquine for chronic babesiosis with fatigue

This study tests an oral medication, tafenoquine, to see if it helps people with chronic babesiosis who have ongoing fatigue and other symptoms. It aims to find a better treatment for this tick-borne infection that keeps coming back.

New York, New York
NCT06859619Not yet recruiting
Infection exposure study for Montpellier zoo and green space workers

This study checks whether workers in Montpellier's zoo, green spaces, or Ecolothèque have been exposed to germs from animals. It uses a blood test to look for past infections, which may help protect workers in similar jobs.

Montpellier, herault
NCT06207370Recruiting· Phase 2
Tafenoquine plus standard care for babesiosis

This study tests whether adding the oral drug tafenoquine to standard care works better than standard care plus a placebo for treating babesiosis, a tick-borne illness. You must be hospitalized with active symptoms.

Boston, Massachusetts

Hear when a new Human Babesiosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.